We observed no effect of PLX73086 treatment on body weight or plasma NfL levels in either male or female Tg2541 mice (Fig. 5a–d), indicating that peripheral CSF1R inhibition does not impact tauopathy-driven phenotypes. The gene discussed is CSF1R; the disease is tauopathy.